Lodestar Universal has bagged the media mandate for Zandu Pharmaceuticals. The company was in talks with a few agencies for the last three months, and there was no official pitch before taking a decision to sign Lodestar Universal. Though neither the client nor the agency could be contacted at the time of filing the report, it is reliably learnt that the business is in the vicinity of Rs 20 crore to Rs 25 crore.
Zandu Pharmaceuticals was so far taking care of its media business through in-house resources. Industry sources stated that the move to sign a media agency came in the wake of the company’s decision to lay down a strategic communication plan in order to further strengthen its presence in the market.
Major products of the company include Zandu Balm, Zandu Chyawanprash, Zandu Kesari Jeevan, and Zandu Pancharisht, among others. Apart from being major revenue earners for the company, these products also command significant market share in their respective segments.
Zandu manufactures a wide range of ayurvedic medicines, specialising in rheumatology, gynaecology and the central nervous system. The company has four manufacturing units and it manufactures more than 300 ayurvedic medicinal products in the form of pills / tablets, churnas, ointments, syrups and rasas. Zandu has over the last nine decades established brands in these domains.